TECLens: Funding, Investors & Team (Aug 2026)
TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy eyes and individuals with keratoconus. This technology can help patients with presbyopia regain their ability to read from a distance, manage progressive myopia in children, correct vision issues like hyperopia and low-order myopia in adults, and offer other benefits.
TECLens has raised $23.6M across 3 funding rounds on record, the most recent a Series A of $10.0M announced in Aug 2026.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
TECLens Company Profile and Key Stats
Latest funding round on record: Aug 2026.
TECLens Funding Rounds
TECLens raised $4.3M in an undisclosed round announced in Jun 2024.
8 months later, a Series A of $9.3M was announced in Feb 2025.
1.5 years later, a Series A of $10.0M was announced in Aug 2026.
TECLens Investors
TECLens Founders and Leadership Team
Contact details for the TECLens team: 3 of 3 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →TECLens Funding Compared to Other Health Care Startups
TECLens' latest round of $10.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like TECLens in Health Care and New York
Companies Similar to TECLens
https://metriport.com
There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…
Serif Health provides healthcare price intelligence and contract management solution.
Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…
Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…
Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.
Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…
Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s…
Happy Health is a mission-driven technology company committed to transforming mental health awareness through…
Leal Therapeutics creates new treatments for patients.
Teal Health is on a mission to empower women when it comes to their health – starting with at-home cervical…
Livingston Hospital and Healthcare Services Provide personalized, high-quality healthcare, responsive to the…
TECLens Funding FAQs
What does TECLens do?
TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy eyes and individuals with keratoconus. This technology can help patients with presbyopia regain their ability to read from a distance, manage progressive myopia in children, correct vision issues like hyperopia and low-order myopia in adults, and offer other benefits.
How much funding has TECLens raised?
TECLens has raised $23.6M across 3 rounds on record. The most recent is a Series A of $10.0M announced in Aug 2026.
When did TECLens last raise funding?
TECLens' most recent funding round on record is a Series A of $10.0M, announced in Aug 2026.
Who has invested in TECLens?
Investors on record for TECLens include Johnson & Johnson Innovation, Sunmed Capital, Yonjin Venture, Rimonci Capital.
Who founded TECLens?
FundedIQ lists David Acker (Founder) at TECLens.
Who is the CEO of TECLens?
Thomas Dunlap is listed as Chief Executive Officer/ Board of Directors at TECLens.
Where is TECLens headquartered?
TECLens is based in New York, United States.
How many employees does TECLens have?
TECLens is in the 1-10 employee band.
When was TECLens founded?
TECLens was founded in 2013.
How does TECLens' funding compare to other Health Care startups?
TECLens' latest round of $10.0M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's TECLens Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for TECLens is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.